An intriguing insight into the effect of gene dosage on CoO in liver cancer came from a study investigating the impact of KrasG12D activation in the mouse liver in the context of a different number of gene copies encoding Pten tumor suppressor [68]. The gene discussed is PTEN; the disease is liver cancer.